Rec­om­men­da­tions

2.19 An­nu­al screen­ing for cys­tic fibro­sis–re­lat­ed di­a­betes with an oral glu­cose tol­er­ance test should begin by age 10 years in all pa­tients with cys­tic fibro­sis not pre­vi­ous­ly di­ag­nosed with cys­tic fibro­sis–re­lat­ed di­a­betes. B

2.20 A1C is not rec­om­mend­ed as a screen­ing test for cys­tic fibro­sis–re­lat­ed di­a­betes. B

2.21 Pa­tients with cys­tic fibro­sis–re­lat­ed di­a­betes should be treat­ed with in­sulin to at­tain in­di­vid­u­al­ized glycemic goals. A

2.22 Be­gin­ning 5 years after the di­ag­no­sis of cys­tic fibro­sis–re­lat­ed di­a­betes, an­nu­al mon­i­tor­ing for com­pli­ca­tions of di­a­betes is rec­om­mend­ed. E